Gastrointestinal Stents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Biliary Stent, Colonic Stent, Duodenal Stent, Esophageal Stent, Pancreatic Stent), By Application (Biliary Disease, Colorectal Cancer, Stomach Cancer, Inflammatory Bowel Disease, Others), By Region, and By Competition 2020-2030F

Market Overview

Global Gastrointestinal Stents Market has valued at USD 512.75 million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.38% through 2030. The Global Gastrointestinal Stents Market is a dynamic and rapidly evolving sector within the medical device industry. Gastrointestinal stents are specialized medical devices designed to provide relief and support for patients with various gastrointestinal conditions. These stents are typically made of materials such as metal or plastic and are used to maintain the patency (openness) of gastrointestinal structures, including the esophagus, stomach, small intestine, and colon. For instance, in March 2024, Japan-based Olympus Corporation announced the decision to withdraw its planned acquisition of a South Korean stent manufacturer. This unexpected move marked a significant shift in Olympus's strategic objectives, potentially reflecting a reevaluation of its business priorities or market conditions, as the company continues to focus on strengthening its presence in the global medical device sector.

Key Market Drivers

Rising Prevalence of Gastrointestinal Disorders

The global gastrointestinal stents market is witnessing significant growth, and one of the key driving forces behind this expansion is the escalating prevalence of gastrointestinal disorders. These disorders, ranging from colorectal cancer to strictures and obstructions, have become increasingly common in today's world. For instance, according to the article published in National  Library of Medicine, 2021, over 40% of individuals globally experience functional gastrointestinal disorders (FGIDs), significantly impacting their quality of life and increasing the demand for healthcare services.

Gastrointestinal disorders, such as colorectal cancer, esophageal strictures, and inflammatory conditions, have become more prevalent in recent years. These disorders have a substantial impact on patients' quality of life and necessitate effective treatment solutions. As the global population grows and ages, the incidence of these disorders is expected to rise, driving the demand for gastrointestinal stents.

One of the significant demographic shifts of the 21st century is the aging of the global population. The elderly are at a higher risk of developing gastrointestinal conditions, as aging is associated with an increased likelihood of cancers and age-related gastrointestinal diseases. This demographic trend directly correlates with the growth of the gastrointestinal stents market.

Advancements in medical diagnostics have enabled healthcare providers to detect gastrointestinal disorders at earlier stages. Improved screening, endoscopy, and imaging technologies have led to quicker and more accurate diagnoses. With early detection, there is a greater opportunity to treat these conditions effectively, often through the use of gastrointestinal stents.

Gastrointestinal stents offer a minimally invasive treatment option for a variety of gastrointestinal disorders. Patients and healthcare providers increasingly prefer these less invasive procedures, as they typically involve shorter hospital stays, reduced pain, and quicker recovery times. The rising prevalence of gastrointestinal disorders is pushing the adoption of these stents as a preferred treatment option.

The deployment of gastrointestinal stents can significantly improve patient outcomes. They help relieve symptoms, such as difficulty swallowing or bowel obstructions, and can be lifesaving in cases of cancer-related blockages. These positive patient outcomes encourage more patients and healthcare providers to consider stent placement as a viable treatment option.

Technological advancements have made gastrointestinal stents more effective, durable, and less likely to cause complications. Innovations such as self-expanding stents and biodegradable stents have enhanced the scope and safety of stent applications. These developments boost patient and physician confidence in stent usage.

Increased awareness among patients regarding gastrointestinal disorders and the available treatment options is another key driver. As individuals become more informed about their health, they are more likely to seek prompt medical attention and consider the benefits of stent placement.

Minimally Invasive Procedures

The global gastrointestinal stents market is experiencing substantial growth, and a significant factor contributing to this expansion is the increasing preference for minimally invasive procedures. Minimally invasive techniques have revolutionized the field of medical intervention, offering patients and healthcare providers numerous benefits.

Minimally invasive procedures, including endoscopic stent placement, are designed to minimize patient discomfort. Unlike traditional open surgeries, these procedures involve smaller incisions or no incisions at all, resulting in less pain, reduced post-operative pain medication requirements, and a shorter recovery period. Patients are often more willing to undergo procedures when they know they can expect a higher degree of comfort during and after the intervention.

Minimally invasive procedures are often associated with shorter hospital stays. Patients can return home or resume their daily activities sooner, reducing the emotional and financial burdens of extended hospitalization. This benefit is particularly significant for gastrointestinal stents, which are frequently used to address urgent medical conditions such as obstructions and strictures.

The shorter recovery time associated with minimally invasive procedures is a major factor driving their popularity. Patients can return to their normal activities, including work, family, and social life, more rapidly. This is especially important for individuals with gastrointestinal disorders, as it allows them to regain their quality of life swiftly.

Minimally invasive procedures are generally safer than their open surgery counterparts. They involve fewer risks of complications, such as infections or excessive bleeding, and reduce the overall stress on a patient's body. As a result, healthcare providers and patients are more inclined to choose minimally invasive stent placement over traditional surgical options.

Minimally invasive procedures often leave smaller, less noticeable scars than open surgeries. Patients appreciate the improved cosmetic outcomes, especially when the procedure involves a visible or sensitive area like the abdomen or esophagus. This cosmetic benefit can positively influence patients' decision-making when considering gastrointestinal stent placement.

Minimally invasive procedures, such as endoscopy, enable healthcare providers to precisely target and treat specific areas of the gastrointestinal tract. This precision can improve patient outcomes by directly addressing the underlying issues and minimizing collateral damage to surrounding healthy tissue.

Patients who undergo minimally invasive procedures tend to report higher levels of satisfaction compared to those who have open surgeries. The positive experience and outcomes associated with these procedures often lead to word-of-mouth referrals, further driving the adoption of minimally invasive stent placement.

Growing Awareness and Diagnosis

The global gastrointestinal stents market is experiencing remarkable growth, driven by several key factors, one of which is the growing awareness and early diagnosis of gastrointestinal disorders.

Awareness is the cornerstone of effective healthcare. Patients and healthcare providers alike are increasingly informed about gastrointestinal disorders, their symptoms, and the available treatment options. Greater awareness among the general public means that individuals are more likely to seek medical attention when they experience symptoms related to these disorders. This increased awareness plays a pivotal role in driving the growth of the gastrointestinal stents market. In August 2021, the importance of raising awareness about gastrointestinal manifestations in patients with human inborn errors of immunity (IEI) was emphasized. IEI encompasses a diverse and expanding group of over 350 genetic disorders that impair the development or function of components within the innate and adaptive immune systems, highlighting the critical need for improved understanding and management of these conditions.

As awareness of gastrointestinal disorders grows, patients are becoming more adept at recognizing early symptoms. Whether it's difficulty swallowing, abdominal pain, or changes in bowel habits, people are quicker to acknowledge these warning signs and seek medical advice. Early symptom recognition often leads to timely diagnoses, which in turn drives the demand for effective treatment options, such as gastrointestinal stents.

The medical field has made significant advancements in diagnostic technologies. Improved screening, imaging, and endoscopy procedures have made it easier to detect and diagnose gastrointestinal disorders accurately. These technologies allow healthcare providers to identify the specific condition and its severity, which guides treatment decisions. This precision in diagnosis has increased the demand for stent placement in the gastrointestinal tract.

Early diagnosis of gastrointestinal disorders provides an opportunity for early intervention. In many cases, these conditions can be treated more effectively when detected in their initial stages. Gastrointestinal stents serve as an essential tool for early intervention, as they can alleviate symptoms, maintain patency, and prevent complications associated with disorders such as strictures and obstructions.

Support groups and patient advocacy organizations have played a crucial role in spreading awareness about gastrointestinal disorders. These groups provide a platform for patients to share their experiences, educate others, and advocate for increased research and treatment options. Their efforts contribute to the general understanding of these conditions, reducing stigma and promoting early diagnosis and treatment.

The medical community plays an essential role in raising awareness about gastrointestinal disorders. Continued education and training for healthcare providers ensure that they remain updated on the latest diagnostic and treatment options, including the use of gastrointestinal stents. This knowledge empowers healthcare professionals to make informed decisions that benefit patients.

Aging Population

The global gastrointestinal stents market is experiencing robust growth, and one of the significant driving forces behind this expansion is the aging population. As the world's demographics shift, with an increasing number of elderly individuals, the incidence of age-related gastrointestinal disorders rises. For instance, according to the World Health Organization, the global population is aging rapidly. By 2030, one in six people worldwide will be aged 60 or older, with the number of individuals in this age group increasing from 1 billion in 2020 to 1.4 billion. By 2050, this figure will double to 2.1 billion, while the population aged 80 and above is projected to triple, reaching 426 million.

The world is witnessing an unprecedented demographic shift towards an older population. People are living longer, thanks to advancements in healthcare and improved living conditions. With this demographic change, there is an increasing prevalence of age-related health issues, including gastrointestinal disorders such as colorectal cancer, strictures, and obstructions.

As individuals age, the risk of developing gastrointestinal disorders tends to increase. Conditions like colorectal cancer, esophageal strictures, and inflammatory diseases become more prevalent in older individuals. This direct correlation between aging and gastrointestinal disorders is a key driver of the growth of the gastrointestinal stents market.

Colorectal cancer is one of the most common gastrointestinal cancers, and its incidence increases with age. Elderly individuals are more likely to develop this type of cancer, often necessitating interventions like stent placement to alleviate obstructions and maintain the patency of the gastrointestinal tract.

With age, the gastrointestinal tract undergoes changes that can lead to various issues. These include decreased motility, weakening of the muscular walls, and the development of diverticula and strictures. Gastrointestinal stents can address these age-related anatomical changes, making them essential for the older population.

Advancements in healthcare and improved access to medical services have extended life expectancy. This increased longevity, while a positive development, also means that more individuals are at risk of age-related gastrointestinal disorders. This demographic shift is a fundamental factor driving the growth of the gastrointestinal stents market.

Gastrointestinal stents, whether used for palliative care in advanced age or as a temporary measure for elderly patients, can significantly improve the quality of life. They provide relief from symptoms such as difficulty swallowing, abdominal pain, or bowel obstructions, allowing elderly individuals to enjoy a better quality of life in their later years.

The aging population has led to a growing demand for geriatric healthcare services. Healthcare providers are increasingly equipped to diagnose and treat age-related gastrointestinal disorders, including stent placement, in a manner that is sensitive to the specific needs of older patients. 

Download Free Sample Report

Key Market Challenges

Risk of Complications

While gastrointestinal stents are life-saving devices for many patients, they are not without risks. Complications such as stent migration, perforation, and infection can occur. Balancing the benefits of stent placement with the risks and complications remains a challenge for healthcare providers and patients alike.

Cost Considerations

The cost of gastrointestinal stent placement can be significant, particularly when factoring in the device itself, the procedure, and follow-up care. The cost considerations can impact the accessibility of stent placement, as not all patients may have access to the necessary financial resources or health insurance coverage.

Complications Arising from Long-Term Stent Placement

In cases where patients require long-term stent placement, complications may arise over time. Stent occlusion, migration, or the development of new obstructions are all potential issues. Patients may require repeated procedures or intervention, which can be emotionally and financially taxing.

Key Market Trends

Biodegradable Stents

One of the most promising trends in the gastrointestinal stents market is the development of biodegradable stents. These stents are designed to gradually break down and be absorbed by the body over time, eliminating the need for removal or replacement. Biodegradable stents offer potential advantages, such as reducing the risk of complications and obviating the need for follow-up procedures.

Integration of Drug-Eluting Stents

The integration of drug-eluting capabilities into gastrointestinal stents is another significant trend. Drug-eluting stents are designed to release medications directly to the affected area, reducing inflammation and minimizing tissue overgrowth. These stents have the potential to improve patient outcomes and reduce complications associated with stent placement.

Expansion of Minimally Invasive Techniques

Minimally invasive procedures are becoming the standard of care across various medical specialties. The gastrointestinal stents market is no exception. As technology and techniques continue to advance, healthcare providers will increasingly turn to minimally invasive procedures to diagnose and treat gastrointestinal disorders, contributing to the growth of the market.

Segmental Insights

Product Type Insights

Based on the category of Product Type, Biliary stents are poised to dominate the Global Gastrointestinal Stents Market for several compelling reasons. Firstly, a growing incidence of biliary disorders, such as obstructive jaundice and cholangitis, has heightened the demand for biliary stenting procedures. This is further accentuated by an ageing population, which is more susceptible to such conditions. Secondly, biliary stents have demonstrated their effectiveness in providing relief and facilitating better patient outcomes, driving increased adoption among healthcare practitioners. The technological advancements have led to the development of more sophisticated and durable biliary stents, enhancing their efficacy and safety. The competitive landscape also favors biliary stents, as key market players have been investing heavily in research and development to improve these devices. Given these factors, biliary stents are well-positioned to dominate the Global Gastrointestinal Stents Market, capitalizing on their efficacy, growing demand, and technological advancements.

Application Insights

Based on Application, Colorectal Cancer is expected to grow during the forecast years. This escalation in colorectal cancer cases can be primarily attributed to the substantial global incidence rates. Moreover, the burgeoning elderly population is a prominent contributing factor, given that advanced age represents the most critical risk factor for this disease.

To illustrate the scope of this issue, data from the American Cancer Society in 2020 revealed that the lifetime risk of developing colorectal cancer stands at approximately 1 in 22, equating to 4.49% for men and 1 in 24, or 4.15% for women. The same report indicated that approximately 53% of colorectal cancer cases are concentrated in developed countries with a Human Development Index (HDI) above 0.8. These nations, though home to less than a quarter of the global population, disproportionately harbor a substantial number of individuals afflicted by colorectal cancer. Similarly, as per the 2021 report from the Indian Council of Medical Research, the incidence of colorectal cancer in 2021 was roughly 3.9 per 100,000 women and 4.4 per 100,000 men throughout the country. This report also emphasized the escalating trend in colorectal cancer cases in India. Consequently, given the mounting instances of colorectal cancer, the market under consideration is poised for robust growth in the upcoming forecast period.

In addition, a study published in the Digestive Medicine Research (DMR) Journal in June 2021 highlighted the global attention that stenting is garnering as a treatment option for colorectal cancer. Minimally invasive surgical procedures, which facilitate quicker patient recovery, are becoming increasingly prevalent in various healthcare facilities. This trend is attributable to the acknowledged importance of gastrointestinal stents and the presence of multinational corporations in the stenting sector. Consequently, it is anticipated that the stenting segment will experience growth during the forecasted period.

Download Free Sample Report

Regional Insights

In the forthcoming period, North America is poised to assert its dominance in the Gastrointestinal Stent Market. This region boasts one of the most advanced medical device industries globally and is projected to take the lead in the market under consideration. The driving factors behind this commanding market position include the increasing prevalence of obstructive gastrointestinal conditions, favorable reimbursement policies, the aging demographic, and the presence of major industry players. For instance, data from the Centers for Disease Control and Prevention in 2020 indicated that 14.8 million adults were diagnosed with ulcers in the United States, while 7.9 million visits to emergency departments listed diseases of the digestive system as the primary diagnosis.

The impact of COVID-19 has been notably severe in patients with co-morbid conditions, particularly those who are immunosuppressed, malnourished, or immunocompromised. Notably, inflammatory bowel disease (IBD), which encompasses conditions like Crohn's disease and ulcerative colitis, posed unique challenges for gastroenterologists during the COVID-19 pandemic in the United States, as revealed by a study conducted by Maliha Naseer and published in the World Journal of Meta-Analysis in October 2020. During the pandemic, IBD patients continued their medication regimens and adhered to universal precautions, albeit experiencing some short-term market disruptions due to the pandemic's impact.

Recent Developments

• In February 2023, Olympus Corporation announced the acquisition of Taewoong Medical Co., Ltd, a prominent manufacturer of medical devices, including gastrointestinal (GI) metallic stents. This strategic move enabled Olympus to broaden its GI EndoTherapy product portfolio, addressing a wider range of clinical needs. Additionally, the acquisition strengthened the company’s research and development capabilities, fostering innovation, while also driving business growth by expanding market presence and increasing overall revenue in the healthcare sector. 
• In June 2024, Boston Scientific Corporation announced a definitive agreement to acquire Silk Road Medical, Inc., a renowned medical device company specializing in innovative stroke prevention solutions for patients with carotid artery disease. Silk Road Medical’s flagship technology, the transcarotid artery revascularization (TCAR) procedure, is a minimally invasive approach that improves patient outcomes while significantly reducing stroke risk. This acquisition enhances Boston Scientific’s vascular portfolio and reinforces its leadership in advanced medical technologies.
• In June 2022, Boston Scientific Corporation entered into a strategic agreement with Synergy Innovation Co., Ltd. to acquire a majority stake in M.I.Tech Co., Ltd., a leading manufacturer of HANAROSTENT technology. These non-vascular, self-expanding metal stents are known for their conformable design. This acquisition enabled Boston Scientific to integrate advanced stent technologies, expand its customer base, strengthen its product portfolio, and gain a significant competitive edge in the medical devices market.
• In October 2020, Olympus introduced the HANAROSTENT Esophagus Through-the-Scope (TTS) Stent, expanding its gastrointestinal product portfolio. This advanced stent is designed for use in minimally invasive procedures, offering precision and reliability for the treatment of esophageal conditions. By providing enhanced patient comfort and ease of deployment for healthcare professionals, the HANAROSTENT TTS Stent underscores Olympus's commitment to innovation in medical technology, addressing critical needs in gastrointestinal health care.

Key Market Players

• Boston Scientific Corporation
• Cook Group Inc
• Becton Dickinson & Co Ltd
• CONMED Corporation
• Cantel Medical LLC
• ELLA-CS, s.r.o.
• Hobbs Medical Inc.
• Merit Medical Systems, Inc.
• Olympus Corp
• Diagmed Healthcare Ltd

Report Scope:

In this report, the Global Gastrointestinal Stents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Gastrointestinal Stents Market, By Product Type:

o   Biliary Stent

o   Colonic Stent

o   Duodenal Stent

o   Esophageal Stent

o   Pancreatic Stent

• Gastrointestinal Stents Market, By Application:

o   Biliary Disease

o   Colorectal Cancer

o   Stomach Cancer

o   Inflammatory Bowel Disease

o   Others

• Gastrointestinal Stents Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  Germany

§  United Kingdom

§  France

§  Italy

§  Spain

o   Asia-Pacific

§  China

§  Japan

§  India

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Gastrointestinal Stents Market.

Available Customizations:

Global Gastrointestinal Stents market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Gastrointestinal Stents Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com